BIOMARIN PHARMACEUTICAL INC Other Comprehensive Income (Loss), before Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Comprehensive Income (Loss), before Tax of -$10.23 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2015-11-02
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for the quarter ending 2015-09-30 was -$10.23M, a 170.74% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for the quarter ending 2015-06-30 was -$13.34M, a 418.55% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for the quarter ending 2015-03-31 was $20.51M, a 478.65% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for the quarter ending 2014-12-31 was $4.03M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for fiscal 2014 was $26.23M, a 230.41% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before tax for fiscal 2013 was $7.94M.
| Period end | Other Comprehensive Income (Loss), before Tax 3 month | Other Comprehensive Income (Loss), before Tax 3 month as first filed | Other Comprehensive Income (Loss), before Tax 6 month | Other Comprehensive Income (Loss), before Tax 9 month | Other Comprehensive Income (Loss), before Tax 9 month as first filed | Other Comprehensive Income (Loss), before Tax 12 month |
|---|---|---|---|---|---|---|
| 2015-09-30 | -$10.23M 10-Q · filed 2015-11-02 | -$23.57M derived: sum of 2 quarters · filed 2015-11-02 | -$3.06M 10-Q · filed 2015-11-02 | $967.00K derived: sum of 4 quarters · filed 2015-11-02 | ||
| 2015-06-30 | -$13.34M 10-Q · filed 2015-08-05 | $7.17M 10-Q · filed 2015-08-05 | $11.20M derived: sum of 3 quarters · filed 2015-08-05 | $25.66M derived: sum of 4 quarters · filed 2015-11-02 | ||
| 2015-03-31 | $20.51M 10-Q · filed 2015-05-05 | $24.54M derived: sum of 2 quarters · filed 2015-05-05 | $39.01M derived: sum of 3 quarters · filed 2015-11-02 | $43.19M derived: sum of 4 quarters · filed 2015-11-02 | ||
| 2014-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $18.49M derived: sum of 2 quarters · filed 2015-11-02 | $22.68M derived: sum of 3 quarters · filed 2015-11-02 | $26.23M 10-K · filed 2015-03-02 | ||
| 2014-09-30 | $14.46M 10-Q · filed 2015-11-02 | $18.65M derived: sum of 2 quarters · filed 2015-11-02 | $22.20M 10-Q · filed 2015-11-02 | $22.20M 10-Q · filed 2014-10-28 | $12.93M derived: sum of 4 quarters · filed 2015-11-02 | |
| 2014-06-30 | $4.19M 10-Q · filed 2015-08-05 | $4.19M 10-Q · filed 2014-07-31 | $7.73M 10-Q · filed 2015-08-05 | -$1.53M derived: sum of 3 quarters · filed 2015-08-05 | $11.65M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $3.54M 10-Q · filed 2015-05-05 | -$5.72M derived: sum of 2 quarters · filed 2015-05-05 | $7.46M derived: sum of 3 quarters · filed 2015-05-05 | $9.44M derived: sum of 4 quarters · filed 2015-05-05 | ||
| 2013-12-31 | -$9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $3.92M derived: sum of 2 quarters · filed 2015-03-02 | $5.90M derived: sum of 3 quarters · filed 2015-03-02 | $7.94M 10-K · filed 2015-03-02 | ||
| 2013-09-30 | $13.18M 10-Q · filed 2014-10-28 | $15.16M derived: sum of 2 quarters · filed 2014-10-28 | $17.20M 10-Q · filed 2014-10-28 | |||
| 2013-06-30 | $1.98M 10-Q · filed 2014-07-31 | $4.02M 10-Q · filed 2014-07-31 | ||||
| 2013-03-31 | $2.04M 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |